Gilde Healthcare logo

Gilde Healthcare

Europe, Utrecht, The Netherlands, Utrecht

Description

Gilde Healthcare is a healthcare investor that does lower mid-market buyouts and later stage venture.

Investor Profile

Gilde Healthcare has made 117 investments, with 14 in the past 12 months and 38% as lead.

Stage Focus

  • Series B (21%)
  • Series C (19%)
  • Series A (17%)
  • Series Unknown (13%)
  • Series D (13%)
  • Private Equity (9%)
  • Series E (5%)
  • Series F (2%)
  • Seed (1%)
  • Series G (1%)

Country Focus

  • United States (33%)
  • The Netherlands (19%)
  • United Kingdom (9%)
  • Denmark (9%)
  • Germany (8%)
  • Switzerland (6%)
  • Ireland (5%)
  • Belgium (4%)
  • France (3%)
  • Spain (3%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Medical Device
  • Pharmaceutical
  • Therapeutics
  • Biopharma
  • Health Diagnostics
  • Life Science
  • Genetics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Gilde Healthcare frequently co-invest with?

Gimv
Europe, Antwerpen, Belgium, Antwerpen
Co-Investments: 9
Ysios Capital
Europe, Pais Vasco, Spain, San Sebastian
Co-Investments: 14
Advent Life Sciences
Europe, England, United Kingdom, London
Co-Investments: 8
New Enterprise Associates
North America, California, United States, Menlo Park
Co-Investments: 15
Forbion Capital Partners
Europe, Noord-Holland, The Netherlands, Naarden
Co-Investments: 13
Andera Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 6
Novo Holdings
Europe, Hovedstaden, Denmark, Hellerup
Co-Investments: 12
Lightstone Ventures
North America, California, United States, Menlo Park
Co-Investments: 7
Sofinnova Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 11
Morgenthaler Ventures
North America, California, United States, Menlo Park
Co-Investments: 9

Which angels does Gilde Healthcare often collaborate with?

GP
North America, Massachusetts, United States, Cambridge
Shared Deals: 1
JD
Europe, Noord-Brabant, The Netherlands, Eindhoven
Shared Deals: 1

What are some of recent deals done by Gilde Healthcare?

MicroTransponder

Dallas, Texas, United States

MicroTransponder is a medical device company that develops and commercializes neurostimulation devices to treat neurological diseases.

Health CareMedicalMedical Device
Series FMar 12, 2025
Amount Raised: $65,000,000
Shoulder Innovations

Holland, Michigan, United States

Shoulder Innovations is a medical device company that develops inset glenoid fixation technology.

BiotechnologyHealth CareMedical Device
Series EMar 10, 2025
Amount Raised: $40,000,000
GT Medical Technologies

Tempe, Arizona, United States

GT Medical Technologies is a medical device company that offers innovative medical solutions for brain tumor patients.

Health CareMedicalMedical DeviceTherapeutics
Series DJan 16, 2025
Amount Raised: $37,000,000
Alleviant Medical

Austin, Texas, United States

Alleviant Medical develops transcatheter technology designed to lift the clinical and economic burden of heart failure.

BiotechnologyClinical TrialsHealth CareMedical Device
Series UnknownJan 14, 2025
Amount Raised: $90,000,000
FIRE1

Dublin, Dublin, Ireland

FIRE1 and is based in Dublin, Ireland, will focus on developing novel therapeutic devices.

BiotechnologyHealth CareMedical DeviceTherapeutics
Series UnknownJan 7, 2025
Amount Raised: $120,000,000
Noema Pharma

Basel, Basel-Stadt, Switzerland

Noema Pharma is a biotech company that develops therapies to address disabling symptoms in conditions of the brain and nervous system.

BiotechnologyMedicalPharmaceutical
Series BDec 11, 2024
Amount Raised: $30,567,953
ADCendo

Copenhagen, Hovedstaden, Denmark

ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs.

BiotechnologyHealth Care
Series BNov 25, 2024
Amount Raised: $135,000,000
SynOx Therapeutics

Dublin, Dublin, Ireland

SynOx Therapeutics is a biotechnology research company that focused on developing the treatment of diffuse tenosynovial giant cell tumors.

BiotechnologyMedicalTherapeutics
Series BOct 30, 2024
Amount Raised: $92,000,000
Purespring Therapeutics

London, England, United Kingdom

Purespring Therapeutics is a gene therapy company that provides treatments for different kidney diseases.

BiotechnologyMedicalTherapeutics
Series BOct 9, 2024
Amount Raised: $104,529,935
Moximed

Hayward, California, United States

Moximed develops innovative therapies for patients with knee osteoarthritis.

BiotechnologyHealth CareMedical Device
Series DAug 13, 2024
Amount Raised: $61,000,000